Wedbush Securities Inc Clearside Biomedical, Inc. Transaction History

Wedbush Securities Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$1.35 - $2.88 $48,922 - $104,368	-36,239 Closed	0 $0
Q4 2021 Jan 13, 2022	BUY	$2.72 - $5.72 $98,570 - $207,287	36,239 New	36,239 $99,000
Q4 2020 Feb 16, 2021	SELL	$1.32 - $2.74 $27,588 - $57,266	-20,900 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$1.45 - $2.0 $2,900 - $4,000	-2,000 Reduced 8.73%	20,900 $32,000
Q1 2020 Apr 17, 2020	SELL	$1.32 - $3.77 $23,496 - $67,106	-17,800 Reduced 43.73%	22,900 $39,000
Q4 2019 Jan 16, 2020	SELL	$0.62 - $3.4 $12,834 - $70,380	-20,700 Reduced 33.71%	40,700 $118,000
Q3 2019 Oct 17, 2019	BUY	$0.59 - $1.32 $236 - $528	400 Added 0.66%	61,400 $39,000
Q2 2019 Aug 01, 2019	SELL	$0.97 - $1.42 $485 - $710	-500 Reduced 0.81%	61,000 $59,000
Q1 2019 Apr 17, 2019	SELL	$1.1 - $1.74 $1,980 - $3,132	-1,800 Reduced 2.84%	61,500 $85,000
Q4 2018 Jan 31, 2019	SELL	$1.0 - $6.12 $12,250 - $74,970	-12,250 Reduced 16.21%	63,300 $68,000
Q3 2018 Nov 13, 2018	BUY	$6.03 - $11.24 $455,566 - $849,182	75,550 New	75,550 $465,000
Q1 2018 May 01, 2018	SELL	$5.57 - $14.28 $271,882 - $697,035	-48,812 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$5.78 - $9.12 $112,710 - $177,839	19,500 Added 66.53%	48,812 $342,000
Q3 2017 Oct 31, 2017	BUY	$6.73 - $8.74 $197,269 - $256,186	29,312	29,312 $256,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $60.2M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.